These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30543175)

  • 1. HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India.
    Swathirajan CR; Vignesh R; Waldrop G; Shanmugasundaram U; Nandagopal P; Solomon SS; Pradeep A; Saravanan S; Murugavel KG
    Curr HIV Res; 2018; 16(4):302-314. PubMed ID: 30543175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.
    López M; Soriano V; Lozano S; Ballesteros C; Cascajero A; Rodés B; De La Vega E; González-Lahoz J; Benito JM
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1185-95. PubMed ID: 18729773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
    Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ
    BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
    Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
    AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens.
    Valdez H; Carlson NL; Post AB; Asaad R; Heeger PS; Lederman MM; Lehmann PV; Anthony DD
    AIDS; 2002 May; 16(8):1113-8. PubMed ID: 12004269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors.
    Gaardbo JC; Hartling HJ; Ronit A; Thorsteinsson K; Madsen HO; Springborg K; Gjerdrum LM; Birch C; Laye M; Ullum H; Andersen ÅB; Nielsen SD
    PLoS One; 2013; 8(5):e63744. PubMed ID: 23696852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.
    Pernas M; Casado C; Sandonis V; Arcones C; Rodríguez C; Ruiz-Mateos E; Ramírez de Arellano E; Rallón N; Del Val M; Grau E; López-Vazquez M; Leal M; Del Romero J; López Galíndez C
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):225-31. PubMed ID: 23714744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.
    Migueles SA; Mendoza D; Zimmerman MG; Martins KM; Toulmin SA; Kelly EP; Peterson BA; Johnson SA; Galson E; Poropatich KO; Patamawenu A; Imamichi H; Ober A; Rehm CA; Jones S; Hallahan CW; Follmann DA; Connors M
    EBioMedicine; 2015 Jan; 2(1):46-58. PubMed ID: 26137533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
    Migueles SA; Sabbaghian MS; Shupert WL; Bettinotti MP; Marincola FM; Martino L; Hallahan CW; Selig SM; Schwartz D; Sullivan J; Connors M
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2709-14. PubMed ID: 10694578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and function of HIV-specific CD8(+) T cells.
    Migueles SA; Connors M
    Immunol Lett; 2001 Nov; 79(1-2):141-50. PubMed ID: 11595301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME; Shearer WT; Kozinetz CA; Lewis DE
    J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control.
    Whittall T; Peters B; Rahman D; Kingsley CI; Vaughan R; Lehner T
    Clin Exp Immunol; 2011 Nov; 166(2):208-17. PubMed ID: 21985367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers.
    Lind A; Brekke K; Pettersen FO; Mollnes TE; Trøseid M; Kvale D
    PLoS One; 2014; 9(1):e85604. PubMed ID: 24416431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Progression in HIV-1-Infected Viremic Controllers.
    Groves KC; Bibby DF; Clark DA; Isaksen A; Deayton JR; Anderson J; Orkin C; Stagg AJ; McKnight A
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):407-16. PubMed ID: 22902723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Difference in the CD4+T lymphocytes activation between long term non-progressors and typical progressors of HIV-1 infected patients].
    Jiao YM; Fu JL; Zhang Z; Zhang H; Jin L; Zhou CB; Fu BY; Wang FS; Wu H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):11-3. PubMed ID: 17429522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.